What is the therapeutic trough concentration of tobramycin measured six hours after a 5 mg/kg dose in an adult or older child with normal renal function receiving the drug intravenously or intramuscularly every six hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Therapeutic Tobramycin Level 6 Hours After 5 mg/kg Dose

For traditional multiple-daily dosing at 5 mg/kg every 8 hours, a level drawn 6 hours post-dose represents a trough concentration and should be <1 µg/mL to minimize nephrotoxicity and ototoxicity risk. 1

Understanding the Dosing Context

The interpretation of a 6-hour post-dose level depends critically on the dosing regimen being used:

Traditional Multiple-Daily Dosing (Every 8 Hours)

  • At 5 mg/kg every 8 hours, the 6-hour level is essentially a trough (pre-dose) concentration 1
  • The therapeutic trough target is <1 µg/mL to reduce toxicity risk 2
  • Peak concentrations (drawn 30-60 minutes post-infusion) should reach 7-10 µg/mL for efficacy 1
  • This dosing pattern produces only 1-2 hours with undetectable drug levels between doses 1

Once-Daily Extended-Interval Dosing

  • If 5 mg/kg were given as a once-daily dose (which is lower than recommended), a 6-hour level would represent a mid-elimination phase concentration 1
  • Once-daily aminoglycoside dosing is now preferred over multiple-daily dosing for most infections, with comparable efficacy and lower nephrotoxicity risk 1
  • Standard once-daily tobramycin dosing is 7-10 mg/kg every 24 hours, not 5 mg/kg 2

Critical Dosing Principles for Aminoglycosides

Aminoglycosides exhibit concentration-dependent bacterial killing, meaning higher peak concentrations produce greater efficacy 1:

  • Peak-to-MIC ratios >8-10 optimize bacterial eradication 2
  • Extended drug-free intervals (9-11 hours with undetectable levels) reduce toxicity 1
  • AUC/MIC ratio >80-110 correlates with clinical success 2

Specific Clinical Scenarios

Pediatric UTI (2-24 Months)

  • Recommended dose: 5 mg/kg every 8 hours 1
  • At this regimen, a 6-hour level is a trough and should be <1 µg/mL 1
  • Peak levels (30-60 min post-dose) should be 5-10 µg/mL 1

Cystic Fibrosis Patients

  • These patients require higher doses (10 mg/kg/day) due to increased clearance 1
  • Once-daily dosing produces peaks of 25-35 µg/mL with 9-11 hour drug-free intervals 1
  • Traditional 8-hour dosing produces only peaks of 7-10 µg/mL 1

Normal Renal Function Adults

  • Once-daily dosing at 7-10 mg/kg is now standard 2
  • A 5 mg/kg dose every 8 hours is suboptimal—produces inadequate peaks for serious infections 1

Pharmacokinetic Parameters

In patients with normal renal function 3, 4:

  • Half-life: 2-3 hours (range 0.5-3 hours) 3, 4
  • Volume of distribution: 0.22 ± 0.09 L/kg 4
  • Renal clearance: 92% of GFR 3

After a 5 mg/kg dose with normal renal function 3, 5:

  • Peak (30-60 min): 4-6 µg/mL 5
  • 6-hour level: approximately 0.5-1.5 µg/mL (approaching trough) 3, 5
  • 8-hour trough: <1 µg/mL 3

Toxicity Monitoring Thresholds

Trough concentrations >2 µg/mL significantly increase nephrotoxicity and ototoxicity risk 2:

  • Target trough: <1 µg/mL for all dosing regimens 2
  • Nephrotoxicity risk increases with AUC >600-700 mg·h/L over 72 hours 2
  • Baseline and monthly audiograms, vestibular testing, and serum creatinine are mandatory 1

Common Pitfalls to Avoid

  • Never interpret a 6-hour level without knowing the dosing interval—it could be a trough (if q8h) or mid-elimination (if q24h) 1
  • Do not use 5 mg/kg once-daily dosing—this is inadequate for serious infections; use 7-10 mg/kg 2
  • In renal impairment, extend the interval but maintain the mg/kg dose—never reduce the individual dose below 12-15 mg/kg as this compromises concentration-dependent killing 1, 6
  • Peak levels are more important than troughs for efficacy—ensure adequate peaks (>8-10× MIC) 2

Modern Dosing Recommendation

For serious infections in patients with normal renal function, once-daily dosing at 7-10 mg/kg is superior to 5 mg/kg every 8 hours 1, 2:

  • Produces higher peaks (better efficacy) 1
  • Longer drug-free intervals (lower toxicity) 1
  • Simpler administration 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans.

Antimicrobial agents and chemotherapy, 1973

Research

Systematically individualizing tobramycin dosage regimens.

Journal of clinical pharmacology, 1980

Guideline

Amikacin Toxicity Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the maximum recommended dose of tobramycin (aminoglycoside antibiotic) for adults with normal renal function?
What is the recommended dosing frequency of tobramycin for different routes, indications, and renal function levels?
For a 179.4‑lb patient, how should I calculate and administer tobramycin (aminoglycoside) at a total dose of 10 mg/kg per day, including dose per infusion, dosing interval, and required therapeutic drug monitoring?
What intramuscular dosing regimen (dose per injection, volume, injection sites) should be used for a 179.4‑lb (81.4 kg) patient receiving tobramycin 10 mg per kilogram per day?
What are the guidelines for using Tobramycin (an aminoglycoside antibiotic) in a patient, considering factors such as age, renal function, and history of hearing loss?
What are the differential diagnoses and recommended imaging studies for a patient with unilateral right lower‑extremity edema three years after total knee arthroplasty?
How long should unfractionated heparin infusion be continued before transitioning to a direct oral anticoagulant in a patient with acute pulmonary embolism?
What are the recommended starting dose and titration schedule, contraindications, monitoring parameters, and alternative therapies for carvedilol (a non‑selective β‑blocker with α1‑blocking activity) in an adult patient with hypertension and chronic heart failure with reduced ejection fraction?
Why is high fluid intake necessary when taking Jardiance (empagliflozin) to prevent dehydration and related adverse effects?
How does an alkaline gastric environment affect the chemical stability and absorption of Adderall (mixed amphetamine salts) and Vyvanse (lisdexamfetamine)?
What is the appropriate management of acute conjunctivitis in an elderly patient with a documented sulfonamide allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.